Chair: Alka Chaubey, PhD, Chief Medical Officer, Bionano

From Leukemias, to Lymphomas and Myelomas, see how cytogenetic labs are implementing OGM across multiple indications and how the workflow performs in comparison to classic cytogenetic methods. Hear from experts building the framework around OGM implementation and learn about our new software tools tailored for Heme applications.

Login to your account to view sessions On-Demand.

Tiffany Clouston  |  Saint John Regional Hospital

Ying S Zou, MD, PhD, FACMG  |  Director of Cancer Cytogenetics Laboratory, Johns Hopkins University School of Medicine

Guilin Tang, MD, PhD, FACMG  |  Chief, Clinical Cytogenetics, University of Texas, MD Anderson Cancer Center

Yanming Zhang, MD  |  Director, Cytogenetics Laboratory, Memorial Sloan Kettering Cancer Center

Agnes Daudignon  |  Lille Hospital

Adam Smith, PhD, FCCMG, FACMG, erCLG  |  Assistant Professor, Dept. Laboratory Medicine University of Toronto

Daniel Saul, MS  |  Director, Product Management, Bionano

Chair: Alka Chaubey, PhD, Chief Medical Officer, Bionano

Discover how OGM performs for the most challenging Heme indications, such as Multiple Myeloma and Lymphoma, and see the latest results from a groundbreaking prospective study on OGM in Heme. Also, see how experts are utilizing Bionano’s workflow to unveil pathogenic structural variants in solid tumors such as Sarcoma and Neuroblastoma. 

Login to your account to view sessions On-Demand.

Marc-Henri Stern MD, PhD | Team Leader, Institute Curie 

Isabelle Raymound-Bouchard, PhD  |  Spécialiste clinique en biologie médicale, Laboratoire de cytogénétique, Hôpital Maisonneuve-Rosemont

Scott Ryall, PhD  |  Laboratory Genetics & Genomics Fellow, Brigham and Women’s Hospital, Harvard University

Ravindra Kolhe, MD, PhD, FACMG  |  Associate Director for Genomics, Georgia Cancer Center

Trilochan Sahoo, PhD  |  Senior Clinical Laboratory Director, Bionano

Deb Tweddle  |  Cancer Research Centre, Newcastle University

Miriam Bornhorst, MD  |  Associate Professor of Pediatrics, Lurie Children’s Hospital of Chicago, Northwestern University

Adrian M Dubuc, PhD, FACMG  |  Associate Professor of Oncology, Roswell Park Comprehensive Cancer Center

Darisha Jiandani, MS  |  Director, Product Management, Bionano

Chair: Alka Chaubey, PhD, Chief Medical Officer, Bionano

Become inspired by genetic disease research, including the rare and undiagnosed, where OGM was key to the discovery of relevant variants after multiple other methods had failed. Receive updates from major multisite clinical studies where OGM was a key tool for the analysis of pre-natal and post-natal samples, for facioscapulohumeral muscular dystrophy (FSHD), and beyond.  

Login to your account to view sessions On-Demand.

Roger Stevenson,MD  |  Sr. Clinical Geneticist, Equinamitas

Nikhil Sahajpal, PhD FACMG  |  Fellow, Laboratory of Genetics and Genomics, Greenwood Genetic Center

Noemi Buisset, MS  |  Medicover Genetics

Laila El Khattabi  |  Head of Cytogenetic Lab, AP-HP Sorbonne

Maria Clara Bonaglia  |  Head of the Laboratory of Cytogenetics, Scientific Institute E. Medea

Yassmine Akkari, PhD, FACMG  |  Sr. Director, Institute of Genomic Medicine, Nationwide Children’s Hospital

Ulrich Broeckel, MD  |  Professor of Pediatrics, Medicine, and Physiology, Chief, Department of Pediatrics, Medical College of Wisconsin

Madhuri Hegde, PhD, FACMG  |  Sr. Vice President and Chief Scientific Officer, Revvity

Tanushi Sahai, Ms  |  Product Manager, Sample Prep Assays and Automation, Bionano

Chair: Alka Chaubey, PhD, Chief Medical Officer, Bionano

See how OGM serves as a critical genomic integrity tool for multiple Cell and Gene therapy applications, including assessing integrity of iSPCs across multiple therapy development programs. Learn how OGM is supporting the development of in vivo gene therapies and detecting off-target events associated with CRISPR-Cas based genome editing. 

Login to your account to view sessions On-Demand.

Alex Hastie, PhD  |  VP, Clinical and Scientific Affairs, Bionano

Sam Dougaparsad, PhD  |  Sr. Technical Specialist, Bionano

John Yu, MD, PhD  |  Distinguished Chair Professor and Director, Insitute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital and Chang Gung University

Samantha Maragh, PhD  |  Leader, Genome Editing Program, National Institute of Standards and Technology

Andy Pang, PhD  |  Sr. Staff Scientist, Bionano

Owen Pearce, PhD  | Genomic Engineering Research Associate, eGenesis